OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2023
(4)
2022
(4)
2025
(3)
2024
(3)
2021
(2)
2026
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Identification and characterization of the T cell receptor (TCR) repertoire of the cynomolgus macaque (Macaca Fascicularis).
Not available
S-EPMC9465142
|
biostudies-literature
Cite
CD4
+
T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfection.
Not available
S-EPMC11466276
|
biostudies-literature
Cite
CD4
+
T cells are homeostatic regulators during
Mtb
reinfection.
Not available
S-EPMC10769325
|
biostudies-literature
Cite
Single-cell and spatial profiling highlights TB-induced myofibroblasts as drivers of lung pathology.
Not available
S-EPMC12767585
|
biostudies-literature
Cite
Wire- and magnetic-seed-guided localization of impalpable breast lesions: iBRA-NET localisation study.
Not available
S-EPMC10364683
|
biostudies-literature
Cite
Evaluating current acute aortic syndrome pathways: Collaborative Acute Aortic Syndrome Project (CAASP).
Not available
S-EPMC11412149
|
biostudies-literature
Cite
A second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689
|
biostudies-literature
Cite
Postoperative outcomes in oesophagectomy with trainee involvement.
Not available
S-EPMC8763367
|
biostudies-literature
Cite
Whole-genome sequencing reveals host factors underlying critical COVID-19.
Not available
S-EPMC9259496
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets